Heart transplantation

Area of Science:

• Cardiology
• Transplantation Medicine
• Surgical Innovation

Background:

• End-stage heart failure significantly reduces patient quality of life and prognosis, with less than 50% one-year survival.
• Heart transplantation is the definitive treatment for irreversible end-stage heart failure across all age groups.
• Despite its efficacy, donor organ availability limits the widespread application of heart transplantation.

Purpose of the Study:

• To evaluate the outcomes and impact of heart transplantation on patients with end-stage heart failure.
• To highlight the survival rates and quality of life improvements post-transplantation.
• To underscore the persistent challenge of donor organ shortage in heart transplantation.

Main Methods:

• Review of survival data and functional status assessments in heart transplant recipients.
• Analysis of long-term survival statistics following heart transplantation.
• Comparison of pre-operative and post-operative New York Heart Association (NYHA) functional classes.

Main Results:

• Heart transplant recipients show significantly improved survival rates: 86% at one year and over 50% at 10 years.
• Approximately 50% of patients survive beyond 10 years, with 25% living over 18 years post-transplantation.
• Patients' functional status improves dramatically, with most transitioning from NYHA class III-IV to I-II post-transplant.

Conclusions:

• Heart transplantation substantially enhances both survival and quality of life for end-stage heart failure patients.
• Long-term survival rates following heart transplantation have seen considerable improvement.
• The critical shortage of donor hearts remains the primary obstacle to increasing the number of heart transplantations performed.